Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 25

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Recurrent TP53 missense mutation in cancer patients of Arab descent

Zick, Aviad, Kadouri, Luna, Cohen, Sherri, Frohlinger, Michael, Hamburger, Tamar, Zvi, Naama, Plaser, Morasha, Avital, Eilat, Breuier, Shani, Elian, Firase, Salah, Azzam, Goldberg, Yael, Peretz, Tamar·2017·Familial Cancer
DOI 10.1007/s10689-016-9951-z
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10689-016-9951-z

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 24

  1. Walsh T et al (2010) Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 107(28):12629–12633 · DOI · Paper page
  2. Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357(2):154–162 · DOI · Paper page
  3. Easton DF et al (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243–2257 · DOI · Paper page
  4. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329(18):1318–1327 · DOI · Paper page
  5. Rennert G et al (2007) Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357(2):115–123 · DOI · Paper page
  6. Lerer I et al (1998) The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am J Hum Genet 63(1):272–274 · DOI
  7. Sagi M et al (2011) Two BRCA1/2 founder mutations in Jews of Sephardic origin. Fam Cancer 10(1):59–63 · doi:10.1007/s10689-010-9395-9
  8. Zick A, Cohen S, Hamburger T, Goldberg Y, Zvi N, Sagi M, Peretz T (2016) A BRCA1 frame shift mutation in women of kurdish Jewish descent. Open Med J 3:31–36
  9. Goldberg Y et al (2015) Genetic features of Lynch syndrome in the Israeli population. Clin Genet 87(6):549–553 · doi:10.1111/cge.12530
  10. Goldberg Y et al (2010) An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC. Fam Cancer 9(2):141–150 · doi:10.1007/s10689-009-9298-9
  11. Salmon A et al (2007) Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline ‘de-novo’ TP53 mutation. Clin Oncol (R Coll Radiol) 19(7):490–493 · DOI
  12. Kadouri L et al (2007) A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer 7:14 · doi:10.1186/1471-2407-7-14
  13. Chouchane L, Boussen H, Sastry KS (2013) Breast cancer in Arab populations: molecular characteristics and disease management implications. Lancet Oncol 14(10):e417–e424 · DOI · Paper page
  14. Nissan A et al (2004) Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am J Surg 188(1):62–67 · doi:10.1016/j.amjsurg.2003.11.039
  15. El Saghir NS et al (2015) BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer. Oncologist 20(4):357–364 · doi:10.1634/theoncologist.2014-0364
  16. Laitman Y et al (2011) Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Breast Cancer Res Treat 127(2):489–495 · doi:10.1007/s10549-010-1217-0
  17. Yablonski-Peretz T et al (2016) Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel. Breast Cancer Res Treat 155(1):133–138 · DOI
  18. Sidransky D et al (1992) Inherited p53 gene mutations in breast cancer. Cancer Res 52(10):2984–2986
  19. Wang PY et al (2013) Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med 368(11):1027–1032 · DOI · Paper page
  20. Slee EA, O’Connor DJ, Lu X (2004) To die or not to die: how does p53 decide? Oncogene 23(16):2809–2818 · DOI · Paper page
  21. Smith PD et al (1999) Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene 18(15):2451–2459 · DOI
  22. Monti P et al (2011) Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. Mol Cancer Res 9(3):271–279 · DOI
  23. Andrade KC et al (2016) Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation. Genet Mol Biol 39(2):199–202 · DOI
  24. Villani A et al (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 12(6):559–567 · DOI · Paper page

Cited by

See all 25

Metadata

Authors
Zick, A., Kadouri, L., Cohen, S., Frohlinger, M., Hamburger, T., Zvi, N., Plaser, M., Avital, E., Breuier, S., Elian, F., Salah, A., Goldberg, Y., & Peretz, T.
Venue
Familial Cancer
Publisher
Springer Science and Business Media LLC
Published
2016-11-19
Volume
16
Issue
2
Pages
295-301
ISSN
  • 1389-9600
  • 1573-7292
DOI
10.1007/s10689-016-9951-z
Cited by
25
References
1
Language
en
Licence
www.springer.com/tdm (unspecified)
Funders
The Israel Science Fundation (1985/13)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recurrent TP53 missense mutation in cancer patients of Arab descent. https://app.cochat.ai/papers/10.1007/s10689-016-9951-z
The paper
Zick, A., Kadouri, L., Cohen, S., Frohlinger, M., Hamburger, T., Zvi, N., Plaser, M., Avital, E., Breuier, S., Elian, F., Salah, A., Goldberg, Y., & Peretz, T. (2017). Recurrent TP53 missense mutation in cancer patients of Arab descent. Familial Cancer. https://doi.org/10.1007/s10689-016-9951-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.